LISA SHALLENBERGER: Open Payments
NPI 1366969578 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,357 in 88 payments from 12 companies in 2025. Trend: 2023 $3,293 · 2024 $3,970 · 2025 $2,357
Food & beverage: $2,357
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $599 |
| Neurocrine BioSciences, Inc. | 15 | $510 |
| ABBVIE INC. | 14 | $344 |
| Otsuka America Pharmaceutical, Inc. | 4 | $261 |
| Vanda Pharmaceuticals Inc. | 8 | $216 |
| Alkermes, Inc. | 5 | $178 |
| Supernus Pharmaceuticals, Inc. | 11 | $109 |
| Tris Pharma Inc | 3 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Bausch Health US, LLC | 1 | $21 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, FANAPT, REXULTI, LYBALVI, Qelbree, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
